Clinical Roundup NCI study shows physical activities may lower risk of death for older adults September 09, 2022Vol.48 No.32
Clinical Roundup Higher doses of CAR T-cell therapy bring survival advantage for young patients with hard-to-treat B-ALL September 09, 2022Vol.48 No.32
Clinical Roundup Researchers identify markers of chemotherapy resistance and outcome in TNBC September 09, 2022Vol.48 No.32
Clinical Roundup Phase III trial data demonstrates positive results of sugemalimab in stage III NSCLC September 09, 2022Vol.48 No.32
Clinical Roundup Research shows 9/11 disaster site exposure led to doubled risk of myeloma September 09, 2022Vol.48 No.32
Clinical Roundup USC study finds exposure to “forever chemical” PFAS linked to liver cancer in humans September 09, 2022Vol.48 No.32
Clinical Roundup Free educational workshop on conducting sexual and gender minority cancer research available to early career professionals September 09, 2022Vol.48 No.32
Clinical RoundupFree Subcutaneous formulation of Tecentriq demonstrates positive phase III results August 05, 2022Vol.48 No.31
Clinical RoundupFree Thermo Fisher introduces assays for MRD detection in myeloid malignancies August 05, 2022Vol.48 No.31
